The Ethereum Foundation has introduced evm.fast, a public challenge to define an upper bound on the computational steps needed to validate a stateless Ethereum block within a specific software model. This upper bound, called K, measures the evaluator’s workload for all eligible inputs, including startup and execution steps, with limits set on gas and program size. The goal is to quantify the maximum effort required for block validation, aiding Ethereum's move toward mandatory execution proofs that let validators verify blocks without re-executing them. The challenge uses a fixed software environment and does not guarantee full consensus rule implementation or hardware performance metrics.
The Ethereum Foundation's evm.fast challenge aims to set an upper bound on validator workload for Ethereum block validation. For readers following the broader cryptocurrency market, here is Pluang's market snapshot as of Nov 03, 2026 12:21 WIB: out of 50 major cryptocurrencies priced on Pluang, 5 rose and 44 fell today. Notable movers include BAT at Rp2.279 with a 1-day change of -6.62%, AAVE at Rp2.284.536 down 6.18%, and MANA at Rp1.285 down 5.86%.
ZYT officially introduced its Prax Drive System™, a commercial vehicle technology, partnering with leading Chinese truck makers like XCMG, Shacman, and Sinotruk. The system supports heavy trucks, buses, light trucks, and vans, with production underwa...
Rosen Law Firm has initiated an investigation into potential breaches of fiduciary duties by the directors and officers of Monolithic Power Systems, Inc. This legal action could impact shareholders if wrongdoing is found. Investors holding Monolithic...
Ethena's governance forum received a new lending framework proposal aimed at allowing the protocol's trading team to onboard qualified institutional counterparties without needing a separate Risk Committee vote. The framework includes strict checks o...
On November 3, 26 Hyperliquid accounts increased their net long exposure by about $43.8 million across 18 stock-related targets, mainly in technology shares. This move came amid a broader pullback in tech stocks and losses in related contracts, with ...
argenx, an immunology innovation company, announced its management team will participate in two investor conferences in November 2026: the Guggenheim Healthcare Innovation Conference in Boston on November 10 and the Jefferies London Global Healthcare...
